http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017115319-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7a315315c6f04176772cce3218ecd23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8c62833461f651b6de263b9463b3183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b1bd01e12b7602a9a7cd4cafa6811a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f34945c0c31353040a96a9e7108ef1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfe2bdf0fab8d0415da76c3bc97dbe2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_218b42de8384106f6a72898646c745f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0415ddc53c75358fef9b1b4066f646b4 |
| publicationDate | 2017-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017115319-A3 |
| titleOfInvention | Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators |
| abstract | The present invention relates to the use of brassinosteroid analogs for the treatment of dermal disorders or conditions. One embodiment is the topical application of at least one brassinosteroid analog described herein for the treatment of psoriasis in a mammal. The present invention describes the use of brassinosteroid analogs of general formula (a). (a) (I) wherein, R 1 , R 2 , and R3 are selected from H, H0-, linear or branched C1-C4 alkyl, R 5 -O-, HCOO-, R 5 -COO-, -OOC-R 6 -COO-, p-toluene sulphonate, phosphate, tartrate, maleate, sulphate, fluorine, chlorine, bromine, iodine and methanesulphonate, R 4 and R 5 are selected from H and linear or branched C1-C4 alkyl, R 6 is -(CH2)n- wherein n equals to 1, 2 or 3, and can be a single or double bond An embodiment of the present invention describes a method of therapeutic treatment for psoriasis, skin aging, rosacea, dermatitis, burns, skin cancer and malignancies, and pigmentary derangements, by means of administration of brassinosteroid analogs of general formula (a). |
| priorityDate | 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.